TGF-β: The missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

Cytokine and Growth Factor Reviews

Volumn 14, Issue 2, 2003, Pages 85-89

  Chen, WanJun ^a   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Autoimmune diseases; Smad; Suppressor cells; TGF receptor type II; Tolerance

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR;

CYTOTOXIC T LYMPHOCYTE; IMMUNE DEFICIENCY; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; VALIDATION PROCESS;

EID: 0037379654     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00003-0     Document Type: Review

References (35)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.
2. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
3. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001;194:629-44.
4. + suppressor T cellmediated immunosuppression. FASEB J 2002;16:763.6.
5. Kehrl JH, et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-50.
6. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production. J Immunol 1998;160:5719-28.
7. Chen W, Frank ME, Jin W, Wahl SM. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001;14:715-25.
8. Wahl SM, et al. Transforming growth factor-β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 1988;140:3026-32.
9. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455-8.
10. Shevach EM. Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 2001;193:F41-6.
11. Sporn MB. TGF-beta: 20 years and counting. Microb Infect 1999;1:1251-3.
12. Chen W, Wahl SM. TGF-beta: receptors, signaling pathways and autoimmunity. Curr Dir Autoimmun 2002;5:62-91.
13. Gorelik L, Flavell RA. Transforming growth factor-beta in T cell biology. Nat Rev Immunol 2002;2:46-53.
14. Massague J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-91.
15. Roberts AB. The ever-increasing complexity of TGF-beta signaling. Cytokine Growth Factor Rev 2002;13:3-5.
16. Genestier L, Kasibhatla S, Brunner T, Green DR. Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J Exp Med 1999;189:231-9.
17. Piccirillo CA, et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor betal production and responsiveness. J Exp Med 2002;196:237-46.
18. Christ M, et al. Immune dysregulation in TGF-β1 deficient mice. J Immunol 1994;153:1936-46.
19. Chen W, et al. Requirement for transforming growth factor betal in controlling T cell apoptosis. J Exp Med 2001;194:439-54.
20. Fadok VA, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998;101:890-8.
21. Letterio JJ, et al. Maternal rescue of transforming growth factor-β null mice. Science 1994;264:1936-8.
22. Swain SL, Huston LG, Tonkonogy S, Weinberg A. Transforming growth factor-β and IL-4 cause helper T cell precursors develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991;147:2991-3000.
23. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-96.
24. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431-40.
25. Takahashi T, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303-10.
26. Chen W, Jin W, Wahl SM. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J Exp Med 1998;188:1849-57.
27. Gomes NA, Gattass CR, Barreto-De-Souza V, Wilson ME, DosReis GA. TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar. J Immunol 2000;164:2001-8.
28. Kitani A, Chua K, Nakamura K, Strober W. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol 2000;165:691-702.
29. Schneider H, et al. Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signalregulated kinase and c-Jun N-terminal kinase) in CD4(+) T cells from receptor/ligand-deficient mice. J Immunol 2002;169:3475-9.
30. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-42.
31. McHugh RS, et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-23.
32. Green EA, Choi Y, Flavell RA. Pancreatic lymph node-derived CD4(+)CD25(+) T regulatory cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 2002;16:183-91.
33. Tzachanis D, et al. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2001;2:1174-82.
34. Neurath MF, et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002;195:1129-43.
35. Hara M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-96.